The mechanism of histone modifications in regulating enzalutamide sensitivity in advanced prostate cancer

Zhite Zhao1, Yuming Jing1, Zhicheng Xu1

  • 1Department of Urology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi 710032, China.

Insights

Histone modifications in prostate cancer (PCa) drive resistance to enzalutamide (Enz) treatment. Understanding these changes offers new combination therapy strategies to improve CRPC outcomes.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Prostate cancer (PCa) is a leading global cancer in men.
  • Castration-resistant prostate cancer (CRPC) poses significant treatment challenges, especially resistance to enzalutamide (Enz).
  • Histone modifications, including methylation and acetylation, are implicated in the development of Enz resistance.

Purpose of the Study:

  • To review recent findings on how histone modification patterns change during PCa progression and drug resistance.
  • To explore the role of the tumor microenvironment's signaling pathways in regulating histone-modifying enzymes.
  • To discuss potential combination therapies for overcoming Enz resistance in PCa.

Main Methods:

  • Literature review of studies investigating histone modifications in PCa and Enz resistance.
  • Analysis of research on signaling pathways affecting histone-modifying enzymes.
  • Synthesis of current knowledge on therapeutic strategies targeting epigenetic alterations.

Main Results:

  • Altered histone methylation and acetylation patterns are linked to Enz resistance in CRPC.
  • Changes in histone modifications occur in drug resistance-related genes as PCa progresses.
  • Tumor microenvironment signaling pathways influence histone-modifying enzyme activity, impacting Enz efficacy.

Conclusions:

  • Histone modification patterns are critical determinants of enzalutamide efficacy in prostate cancer.
  • Targeting epigenetic alterations offers promising avenues for novel therapeutic strategies.
  • Combination therapies hold potential for reversing drug resistance and improving clinical outcomes in CRPC.

Related Concept Videos

Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
12.8K
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
8.1K
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.3K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
6.6K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
2.9K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
6.8K